ARTICLE | Clinical News
ThGRF regulatory update
March 1, 2010 8:00 AM UTC
FDA extended the PDUFA date to July 27 from March 29 for an NDA from Theratechnologies for tesamorelin to accommodate a rescheduled FDA panel to discuss the application. The meeting of the Endocrinolo...